+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Tuberculosis Testing Market - Global Forecast 2026-2032- Product Image
Tuberculosis Testing Market - Global Forecast 2026-2032- Product Image
New

Tuberculosis Testing Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 196 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4985927
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior decision-makers in global healthcare are witnessing the transformation of the tuberculosis testing market as it advances toward operational integration, diagnostic innovation, and regulatory alignment. Understanding this evolving space is essential for leaders navigating complex supply chain demands and the rising adoption of advanced clinical solutions.

Market Snapshot: Tuberculosis Testing Market Growth & Outlook

The tuberculosis testing market is set for significant expansion, with projections indicating growth from USD 2.35 billion in 2025 to USD 2.49 billion in 2026 and reaching USD 3.68 billion by 2032, driven by a steady CAGR of 6.60%. Ongoing investments in both public and private sectors focus on upgrading diagnostic infrastructures and deploying rapid testing models. The market is benefitting from new platforms, streamlined processes, and regulatory compliance efforts. This forward momentum is supporting laboratory modernization, investment in emerging technologies, and enhancements in operational frameworks to meet rising patient needs and global standards.

Scope & Segmentation of the Tuberculosis Testing Market

This report delivers comprehensive segmentation designed for informed portfolio development, service innovation, and partnership strategy across critical market dimensions relevant to senior decision-makers:

  • Test Types: Includes culture-based, immunological, molecular, and rapid diagnostics suitable for early identification and confirmatory testing.
  • Culture Modalities: Encompasses liquid and solid formats supporting detection acceleration and workflow integration.
  • Immunological Approaches: Covers ELISA and Western blot techniques, advancing diagnostic accuracy in varied clinical settings.
  • Molecular Technologies: Features assays such as PCR and line probe, enabling resistance assessment and alignment with precision medicine initiatives.
  • Rapid Diagnostics: Incorporates chromatographic and lateral flow testing to facilitate accessible, point-of-care services in diverse and underserved regions.
  • End Users: Targets clinics, hospitals, and reference laboratories, each with unique workflow and biosafety requirements supporting a spectrum of patient volumes.
  • Technology Platforms: Ranges from traditional culture to immunodiagnostic and nucleic acid-based systems, meeting technical and resourcing demands across operating environments.
  • Sample Types: Utilizes blood, sputum, and urine, enabling broader clinical access and flexibility.
  • Distribution Channels: Leverages diagnostic labs, hospital pharmacies, and online pharmacies for effective product delivery.
  • Applications: Supports active and latent tuberculosis detection, streamlining screening and confirmatory pathways.
  • Regions: Encompasses Americas, Europe, Middle East & Africa, and Asia-Pacific, reflecting distinct regulatory environments and healthcare capabilities across geographies.

Tuberculosis Testing Market: Key Takeaways for Senior Decision-Makers

  • Molecular decentralization is adjusting diagnostic models, promoting rapid detection and facilitating individualized treatment approaches, especially in regions where resistance trends are shifting.
  • Point-of-care solutions are increasing diagnostic reach by extending capabilities beyond centralized hospital laboratories, enhancing early identification and operational efficiency.
  • Integrated diagnostic strategies that merge rapid molecular and traditional culture techniques are improving infection control and optimizing patient management workflows.
  • Variation in test sample requirements and biosafety protocols is creating new complexities for procurement planning and influencing long-term capital investments.
  • Market success depends on adapting commercial strategies to regional infrastructure and regulatory differences, requiring flexible operational planning.
  • Supplier partnerships and interoperable technologies are increasingly prioritized, with procurement criteria now weighing service quality alongside instrument performance for resilience and continuity.

Tariff Impact on Tuberculosis Diagnostic Supply Chains

Recent United States tariff actions have introduced additional supply chain complexities. Procurement and manufacturing leaders are diversifying suppliers, leveraging extended supplier agreements, and engaging in regional sourcing collaborations to maintain steady supply. Regulatory compliance and partial localization of manufacturing are also mitigating disruption risks and enhancing inventory stability within the tuberculosis testing market.

Strategic Portfolio Adjustments Among Market Leaders

Leading diagnostics companies are refining product portfolios to improve interoperability, system reliability, and modular approaches. Investments in dual-capability platforms—supporting molecular and immunodiagnostic testing—support adaptation to evolving clinical needs. Collaboration among device manufacturers, reagent suppliers, and logistics partners is strengthening supply assurance. Use of real-world performance data and active regulatory engagement is further bolstering payer discussions and fostering lasting adoption in laboratory environments.

Methodology & Data Sources

This analysis is built on a rigorous mixed-methods framework, featuring structured interviews with laboratory directors, clinical microbiologists, procurement executives, and regulatory specialists. Peer-reviewed publications, clinical guideline reviews, and current regulatory materials ensure the findings are practical, reliable, and relevant for strategic planning.

Why This Report Matters

  • Empowers laboratory executives and procurement leaders with actionable insights for technology adoption and workflow refinement in laboratory environments.
  • Informs capital allocation and investment through targeted, segment-level and regional analysis reflecting operational and clinical constraints.
  • Prepares health system leaders to proactively respond to regulatory, tariff, and supply chain challenges, supporting robust, future-ready technology integration.

Conclusion

Tuberculosis testing strategies are progressing rapidly through technological and operational changes. Senior leaders can use these insights to align resources and solutions, driving improved patient care and institutional performance.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Tuberculosis Testing Market, by Test Type
8.1. Culture Test
8.1.1. Liquid Culture
8.1.2. Solid Culture
8.2. Immunological Test
8.2.1. Elisa
8.2.2. Western Blot
8.3. Molecular Test
8.3.1. Line Probe Assay
8.3.2. Pcr
8.4. Rapid Diagnostic Test
8.4.1. Chromatographic
8.4.2. Lateral Flow
9. Tuberculosis Testing Market, by Technology
9.1. Culture Based Technology
9.2. Immunodiagnostic
9.3. Lipoarabinomannan Assay
9.4. Nucleic Acid Amplification Test
10. Tuberculosis Testing Market, by Sample Type
10.1. Blood
10.2. Sputum
10.3. Urine
11. Tuberculosis Testing Market, by End User
11.1. Clinics
11.2. Hospitals
11.3. Reference Laboratory
12. Tuberculosis Testing Market, by Distribution Channel
12.1. Diagnostic Laboratory
12.2. Hospital Pharmacy
12.3. Online Pharmacy
13. Tuberculosis Testing Market, by Application
13.1. Active Tuberculosis
13.2. Latent Tuberculosis
14. Tuberculosis Testing Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Tuberculosis Testing Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Tuberculosis Testing Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Tuberculosis Testing Market
18. China Tuberculosis Testing Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Abbott Laboratories
19.6. Becton Dickinson and Company
19.7. Bio-Rad Laboratories, Inc.
19.8. bioMérieux SA
19.9. Cepheid, Inc.
19.10. Hain Lifescience GmbH
19.11. QIAGEN N.V.
19.12. Roche Diagnostics International Ltd
19.13. Serum Institute of India
19.14. Siemens Healthineers AG
19.15. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL TUBERCULOSIS TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL TUBERCULOSIS TESTING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA TUBERCULOSIS TESTING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY LIQUID CULTURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY LIQUID CULTURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY LIQUID CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY SOLID CULTURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY SOLID CULTURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY SOLID CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY ELISA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY WESTERN BLOT, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY WESTERN BLOT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY WESTERN BLOT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY LINE PROBE ASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY LINE PROBE ASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY LINE PROBE ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY CHROMATOGRAPHIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY CHROMATOGRAPHIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY CHROMATOGRAPHIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY LATERAL FLOW, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY LATERAL FLOW, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY LATERAL FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE BASED TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE BASED TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE BASED TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNODIAGNOSTIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNODIAGNOSTIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNODIAGNOSTIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY LIPOARABINOMANNAN ASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY LIPOARABINOMANNAN ASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY LIPOARABINOMANNAN ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY BLOOD, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY BLOOD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY SPUTUM, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY SPUTUM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY SPUTUM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY URINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY URINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY URINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY REFERENCE LABORATORY, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY REFERENCE LABORATORY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY REFERENCE LABORATORY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY ACTIVE TUBERCULOSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY ACTIVE TUBERCULOSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY ACTIVE TUBERCULOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY LATENT TUBERCULOSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY LATENT TUBERCULOSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY LATENT TUBERCULOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 95. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 96. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2018-2032 (USD MILLION)
TABLE 97. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2018-2032 (USD MILLION)
TABLE 98. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2032 (USD MILLION)
TABLE 99. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
TABLE 100. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 101. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 102. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 103. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 105. NORTH AMERICA TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. NORTH AMERICA TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 107. NORTH AMERICA TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2018-2032 (USD MILLION)
TABLE 108. NORTH AMERICA TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2018-2032 (USD MILLION)
TABLE 109. NORTH AMERICA TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2032 (USD MILLION)
TABLE 110. NORTH AMERICA TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
TABLE 111. NORTH AMERICA TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 116. LATIN AMERICA TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. LATIN AMERICA TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 118. LATIN AMERICA TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2018-2032 (USD MILLION)
TABLE 119. LATIN AMERICA TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2018-2032 (USD MILLION)
TABLE 120. LATIN AMERICA TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2032 (USD MILLION)
TABLE 121. LATIN AMERICA TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 123. LATIN AMERICA TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 124. LATIN AMERICA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2018-2032 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2018-2032 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2032 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 138. EUROPE TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. EUROPE TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 140. EUROPE TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2018-2032 (USD MILLION)
TABLE 141. EUROPE TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2018-2032 (USD MILLION)
TABLE 142. EUROPE TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2032 (USD MILLION)
TABLE 143. EUROPE TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
TABLE 144. EUROPE TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 145. EUROPE TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 146. EUROPE TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 147. EUROPE TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 148. EUROPE TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 149. MIDDLE EAST TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. MIDDLE EAST TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 151. MIDDLE EAST TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2018-2032 (USD MILLION)
TABLE 152. MIDDLE EAST TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2018-2032 (USD MILLION)
TABLE 153. MIDDLE EAST TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2032 (USD MILLION)
TABLE 154. MIDDLE EAST TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
TABLE 155. MIDDLE EAST TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 156. MIDDLE EAST TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 157. MIDDLE EAST TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 158. MIDDLE EAST TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 159. MIDDLE EAST TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 160. AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 161. AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 162. AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2018-2032 (USD MILLION)
TABLE 163. AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2018-2032 (USD MILLION)
TABLE 164. AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2032 (USD MILLION)
TABLE 165. AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
TABLE 166. AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 167. AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 168. AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 169. AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 170. AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 171. ASIA-PACIFIC TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. ASIA-PACIFIC TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 173. ASIA-PACIFIC TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2018-2032 (USD MILLION)
TABLE 174. ASIA-PACIFIC TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2018-2032 (USD MILLION)
TABLE 175. ASIA-PACIFIC TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2032 (USD MILLION)
TABLE 176. ASIA-PACIFIC TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
TABLE 177. ASIA-PACIFIC TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 178. ASIA-PACIFIC TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 179. ASIA-PACIFIC TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 180. ASIA-PACIFIC TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 181. ASIA-PACIFIC TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 183. ASEAN TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. ASEAN TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 185. ASEAN TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2018-2032 (USD MILLION)
TABLE 186. ASEAN TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2018-2032 (USD MILLION)
TABLE 187. ASEAN TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2032 (USD MILLION)
TABLE 188. ASEAN TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
TABLE 189. ASEAN TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 190. ASEAN TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 191. ASEAN TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 192. ASEAN TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 193. ASEAN TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 194. GCC TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 195. GCC TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 196. GCC TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2018-2032 (USD MILLION)
TABLE 197. GCC TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2018-2032 (USD MILLION)
TABLE 198. GCC TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2032 (USD MILLION)
TABLE 199. GCC TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
TABLE 200. GCC TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 201. GCC TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 202. GCC TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 203. GCC TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 204. GCC TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 205. EUROPEAN UNION TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 206. EUROPEAN UNION TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 207. EUROPEAN UNION TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2018-2032 (USD MILLION)
TABLE 208. EUROPEAN UNION TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2018-2032 (USD MILLION)
TABLE 209. EUROPEAN UNION TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2032 (USD MILLION)
TABLE 210. EUROPEAN UNION TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
TABLE 211. EUROPEAN UNION TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 212. EUROPEAN UNION TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 213. EUROPEAN UNION TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 214. EUROPEAN UNION TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 215. EUROPEAN UNION TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 216. BRICS TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 217. BRICS TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 218. BRICS TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2018-2032 (USD MILLION)
TABLE 219. BRICS TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2018-2032 (USD MILLION)
TABLE 220. BRICS TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2032 (USD MILLION)
TABLE 221. BRICS TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
TABLE 222. BRICS TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 223. BRICS TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 224. BRICS TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 225. BRICS TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 226. BRICS TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 227. G7 TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 228. G7 TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 229. G7 TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2018-2032 (USD MILLION)
TABLE 230. G7 TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2018-2032 (USD MILLION)
TABLE 231. G7 TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2032 (USD MILLION)
TABLE 232. G7 TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
TABLE 233. G7 TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 234. G7 TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 235. G7 TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 236. G7 TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 237. G7 TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 238. NATO TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 239. NATO TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 240. NATO TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2018-2032 (USD MILLION)
TABLE 241. NATO TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2018-2032 (USD MILLION)
TABLE 242. NATO TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2032 (USD MILLION)
TABLE 243. NATO TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
TABLE 244. NATO TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 245. NATO TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 246. NATO TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 247. NATO TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 248. NATO TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 249. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 250. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 251. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 252. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2018-2032 (USD MILLION)
TABLE 253. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2018-2032 (USD MILLION)
TABLE 254. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2032 (USD MILLION)
TABLE 255. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
TABLE 256. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 257. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 258. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 259. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 260. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 261. CHINA TUBERCULOSIS TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 262. CHINA TUBERCULOSIS TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 263. CHINA TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE TEST, 2018-2032 (USD MILLION)
TABLE 264. CHINA TUBERCULOSIS TESTING MARKET SIZE, BY IMMUNOLOGICAL TEST, 2018-2032 (USD MILLION)
TABLE 265. CHINA TUBERCULOSIS TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2032 (USD MILLION)
TABLE 266. CHINA TUBERCULOSIS TESTING MARKET SIZE, BY RAPID DIAGNOSTIC TEST, 2018-2032 (USD MILLION)
TABLE 267. CHINA TUBERCULOSIS TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 268. CHINA TUBERCULOSIS TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 269. CHINA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 270. CHINA TUBERCULOSIS TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 271. CHINA TUBERCULOSIS TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Tuberculosis Testing market report include:
  • Abbott Laboratories
  • Becton Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Cepheid, Inc.
  • Hain Lifescience GmbH
  • QIAGEN N.V.
  • Roche Diagnostics International Ltd
  • Serum Institute of India
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages196
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 2.49 Billion
Forecasted Market Value ( USD ) by 2032 $ 3.68 Billion
Compound Annual Growth Rate6.6%
Regions CoveredGlobal
No. of Companies Mentioned12

Related Topics

Related Reports

Mycobacterium Tuberculosis Test Kit Market - Global Forecast 2025-2030 - Product Image

Mycobacterium Tuberculosis Test Kit Market - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Tuberculosis Diagnostics Market - Global Forecast 2026-2032 - Product Image

Tuberculosis Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Tuberculosis Diagnostics Market Report 2025 - Product Image

Tuberculosis Diagnostics Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Tuberculosis Diagnostics Test Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 - Product Image

Tuberculosis Diagnostics Test Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

  • Report
  • 145 Pages
  • Global
From
Tuberculosis Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030 - Product Image

Tuberculosis Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030

  • Report
  • 182 Pages
  • Global
From

About the Tuberculosis Test Market

The Tuberculosis Test market is a subset of the larger Infectious Disease Testing market. It is used to detect the presence of Mycobacterium tuberculosis, the bacteria that causes tuberculosis. Tests are used to diagnose active tuberculosis, as well as to monitor the effectiveness of treatment. Tests can be divided into two categories: those that detect the presence of the bacteria, and those that detect the body's immune response to the bacteria. The most common tests are the tuberculin skin test, the interferon-gamma release assay, and the nucleic acid amplification test. The Tuberculosis Test market is highly competitive, with many companies offering a variety of tests. Some of the major players in the market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.